Celltrion's COVID-19 treatment candidate shows positive results in animal testing
By Kim Han-joo
SEOUL, June 1 (Yonhap) -- South Korean biopharmaceutical firm Celltrion Inc. announced Monday that positive results were shown for its treatment for the novel coronavirus in animal testing.
The company said its antiviral antibody treatment showed a 100-fold reduction in the viral load of SARS-CoV-2, the virus known to be causing COVID-19, in an animal model.
Celltrion also said the treatment candidate showed improvement in lung lesions to a normal activity level in animals.
The antiviral activity at the pre-clinical stage indicates that the candidate could be a potential treatment for COVID-19 if the results are replicated in clinical trials for humans, according to officials.
"Celltrion hopes to commence first-in-human clinical trials in July and has the capability to roll out mass production of the therapeutic antibody treatment once it is ready," Kwon Ki-Sung, head of the R&D unit at Celltrion, said in a press release.
A number of local pharmaceutical companies have joined the global race to develop a vaccine and treatment for COVID-19, but none of them yet have received approval for clinical trials for vaccine or treatment candidates from the country's drug safety agency.
The country reported 35 more cases of COVID-19 due mainly to infections tied to a logistics center in a city just west of Seoul, raising the total caseload to 11,503, according to the Korea Centers for Disease Control and Prevention.
(LEAD) (News Focus) Abrupt replacement of national security adviser gives rise to much speculation
(2nd LD) N. Korea plans to send weapons, munitions to Russia in exchange for food: NSC
Grandson of ex-President Chun released after investigation over drug use
S. Korea releases report on N. Korea's human rights violations
National Assembly consents to arrest of PPP lawmaker Ha
(News Focus) Abrupt replacement of national security adviser gives rise to much speculation
Yoon puts S. Korea-Japan relations back on track
Japan's removal of export curbs on S. Korea to boost supply chain stability, ease biz uncertainties
Yoon's summit with Biden to highlight S. Korea's 'pivotal' role in region: U.S. experts
(News Focus) Solution to forced labor issue shows Yoon's commitment to improving ties with Japan